<DOC>
	<DOC>NCT01055743</DOC>
	<brief_summary>This study will assess the clinical efficacy and safety of fluorouracil implants regional chemotherapy during the surgical treatment for early-stage hepatocellular carcinoma.</brief_summary>
	<brief_title>The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Hepatocellular</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Histological diagnosis of stage I hepatocellular carcinoma ChildPugh class A, B Radical resection is feasible Patients with adequate renal, hepatic, and hematologic function Written informed consent Allergic to chemotherapy drugs No measurable lesion Receive chemotherapy, radiotherapy or biotherapy within 30 days prior to enrollment Evidence of serious infection Renal or hepatic dysfunction, significant cardiovascular disease Pregnant or lactating women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Fluorouracil Implants</keyword>
	<keyword>Hepatocellular carcinoma</keyword>
	<keyword>Radical resection</keyword>
</DOC>